CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. High prevalence of infectious diseases and cancer.
4.1.2. Growth in the number of genomics projects and rising government funding
4.1.3. Technological advancements coupled with genetically modified crops
4.2. Market Restraints & Challenges
4.2.1.Lack of trained professionals and the high cost of genomic equipment
4.2.2. Security issues related to large volumes of data
4.3. Market Opportunities
4.3.1. Use of genome editing in personalised medicine
CHAPTER 5. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET–
BY TECHNOLOGY
5.1. Talen
5.2. Antisense
5.3. ZFN
5.4. Others
CHAPTER 6. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET
– BY APPLICATION
6.1. Cell Line Engineering
6.2. Genome Editing / Genome Engineering
6.2.1. Plant Genome Editing / Genome Engineering
6.2.2. Animal Genome Editing / Genome Engineering
6.3. Others
CHAPTER 7. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET
– BY END USER
7.1. Academic & Government Research Institutes
7.2. Biotechnology & Pharmaceutical Companies
7.3. Contract Research Organizations
CHAPTER 8. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET -
BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. The U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.8. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.8. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET -
COMPANY PROFILES
9.1. Sangamo Biosciences
9.2. Integrated DNA Technologies
9.3. Thermo Fisher Scientific
9.4. Genscript Corporation
9.5. Horizon Discovery Group
9.6. Merck & Co. Pharmaceutical Company
9.7. Crispr Therapeutics
9.8. Transposagen Biopharmaceuticals
9.9. Origene Technologies
9.10. New England Biolabs
9.11. Editas Medicine
9.12. Lonza Group
CHAPTER 10. GLOBAL GENOME EDITING / GENOME ENGINEERING MARKET
- COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
